What's breaking now, across thousands of outlets.
Bayer receives green light in China for new stroke protection. Asundexian is the first drug of a new class of anticoagulants approved there.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.
One in 10 adults in Korea used or was prescribed obesity drugs such as Wegovy and Mounjaro in the past year, with younger generations reporting higher usage and one-third of respondents saying they…
Merck presented its mRNA melanoma vaccine trial data at a European cancer conference this weekend. Results are promising: The vaccine reduces recurrence and death alongside an immunotherapy drug.
People with Alpha-Gal Syndrome can have allergic reactions to meat from mammals. Many of those affected change their diets to eat other proteins.
Zhejiang Wenda Pharma published Phase II clinical trial results at ESMO 2026 for oral BET inhibitor NHWD 870 HCl in patients with advanced NUT carcinoma
According to ARISE News, the woman, who is the wife of a Swiss diplomat in Nigeria, was evacuated early Monday through the private jet wing of the Nnamdi Azikiwe International Airport in Abuja The…
What makes special education teaching jobs so hard to fill? NPR set out to find some answers by talking to more than a dozen teachers who do this work every day.
